Sung-Hyun Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sung-Hyun Kim has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Myoung Ok Kim
Department of Animal Science and Biotechnology, Research Institute for Innovative Animal Science, Kyungpook National University, Sangju, Republic of Korea
2 shared publications - Dong Yep Oh
Gyeongsangbuk-Do Livestock Research institute, Yeongju 36052, Korea
1 shared publication - Duhak Yoon
Department of Animal Science and Biotechnology, Graduate School, Kyungpook National University, Sangju 37224, Republic of Korea
1 shared publication - Jae Jung Ha
Gyeongbuk Livestock Research Institute, Yeongju 36052, Korea
1 shared publication Junkoo Yi
1 shared publication- Junkoo Yi
School of Animal Life Convergence Science, Hankyung National University, Anseong 17579, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 12 February 2019
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 11 (1) , 1-13
Beneficial effects of 6-shogaol on hyperglycemia, islet morphology and apoptosis in some tissues of streptozotocin-induced diabetic mice
Diabetes is characterized by hyperglycemia due to impaired insulin secretion and aberrant glucagon secretion resulting from changes in pancreatic islet cell function and/or mass. The aim of the present study was to investigate the effects of ginger on various tissues (i.e., pancreas, kidney, and liver) and insulin resistance in streptozotocin-induced diabetic mice. The pleasant aroma of ginger comes from the constituents present in its volatile oil, while its non-volatile pungent phytochemicals consist of gingerols, shogaols, and paradols. This research was conducted to determine the effects of 6-shogaol administration on blood glucose and insulin production in type 1 diabetic mice. Mice were intraperitoneally injected with shogaol at 5 or 10 mg/kg body weight. Untreated mice were injected with an equivalent volume of buffer, three times a week for 2 weeks. The animals were randomly divided into four experimental groups: control group mice (n = 3) were given an intraperitoneal (IP) injection of streptozotocin (STZ) vehicle (1 mL citrate buffer/100 g body weight) at day 1 and received an IP injection of 6-shogaol vehicle [1 mL buffer (0.5% DMSO, 10% Tween 20, and 89.5% PBS)/100 g body weight] every other day for 4 consecutive days. 6-Shogaol exhibited an antidiabetic effect by significantly decreased the level of blood glucose, body weight and attenuated the above pathological changes to the normal levels in the diabetic mice, and has effect against pancreas, kidney, liver damage in the diabetic mice. Since, 6-shogaol prevented the damage for STZ induced stress. 6-Shogaol can be used as a therapeutic agent for preventing complications in diabetic patients. Diabetic treatment consider the 6-shogaol as a pharmatheuticals or combination drug with herbal plant or others 6-shogaol may be a good therapeutic drug because it covers not only pancreatic β-cell but also liver and kidney. Ginger may be ideal because they contain a variety of pharmacological compounds with different known pharmacological actions.
- 12 February 2019
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 11 (1) , 1-13
Open AccessBeneficial effects of 6-shogaol on hyperglycemia, islet morphology and apoptosis in some tissues of streptozotocin-induced diabetic mice
Diabetes is characterized by hyperglycemia due to impaired insulin secretion and aberrant glucagon secretion resulting from changes in pancreatic islet cell function and/or mass. The aim of the present study was to investigate the effects of ginger on various tissues (i.e., pancreas, kidney, and liver) and insulin resistance in streptozotocin-induced diabetic mice. The pleasant aroma of ginger comes from the constituents present in its volatile oil, while its non-volatile pungent phytochemicals consist of gingerols, shogaols, and paradols. This research was conducted to determine the effects of 6-shogaol administration on blood glucose and insulin production in type 1 diabetic mice. Mice were intraperitoneally injected with shogaol at 5 or 10 mg/kg body weight. Untreated mice were injected with an equivalent volume of buffer, three times a week for 2 weeks. The animals were randomly divided into four experimental groups: control group mice (n = 3) were given an intraperitoneal (IP) injection of streptozotocin (STZ) vehicle (1 mL citrate buffer/100 g body weight) at day 1 and received an IP injection of 6-shogaol vehicle [1 mL buffer (0.5% DMSO, 10% Tween 20, and 89.5% PBS)/100 g body weight] every other day for 4 consecutive days. 6-Shogaol exhibited an antidiabetic effect by significantly decreased the level of blood glucose, body weight and attenuated the above pathological changes to the normal levels in the diabetic mice, and has effect against pancreas, kidney, liver damage in the diabetic mice. Since, 6-shogaol prevented the damage for STZ induced stress. 6-Shogaol can be used as a therapeutic agent for preventing complications in diabetic patients. Diabetic treatment consider the 6-shogaol as a pharmatheuticals or combination drug with herbal plant or others 6-shogaol may be a good therapeutic drug because it covers not only pancreatic β-cell but also liver and kidney. Ginger may be ideal because they contain a variety of pharmacological compounds with different known pharmacological actions.
- Open Access
- 1 December 2015
- Published by Research Institute of Veterinary Medicine in Journal of Biomedical Research
- Vol. 16 (4) , 165-171
Changes in potassium concentration and gene expression in mice fed a high-fat diet
Journal of Biomedical and Translational Research
- 1 December 2015
- Published by Research Institute of Veterinary Medicine in Journal of Biomedical Research
- Vol. 16 (4) , 165-171
Open AccessChanges in potassium concentration and gene expression in mice fed a high-fat diet
Journal of Biomedical and Translational Research